0% found this document useful (0 votes)
239 views21 pages

Intern Manual

The document outlines clinical guidelines for managing patients presenting with unconsciousness, seizures, and respiratory distress. It includes detailed protocols for assessment, laboratory tests, imaging, and treatment options for various conditions such as CVA, hypoglycemia, DKA, sepsis, and alcohol intoxication. Standard prescriptions and urgent interventions are also specified for effective patient care.

Uploaded by

adrish49
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
239 views21 pages

Intern Manual

The document outlines clinical guidelines for managing patients presenting with unconsciousness, seizures, and respiratory distress. It includes detailed protocols for assessment, laboratory tests, imaging, and treatment options for various conditions such as CVA, hypoglycemia, DKA, sepsis, and alcohol intoxication. Standard prescriptions and urgent interventions are also specified for effective patient care.

Uploaded by

adrish49
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 21

COLLEGEOFMEDI

CINE&JNM HOSPI
TAL,
WBUHS,
KALYANI

DEPARTMENTOFMEDI
CINE

Basi
ccl
ini
calgui
del
inef
orI
nter
neeandJR

Pat
ientpr
esent
edwi
thUNCONCOIUSNESS/STUPOR/
MENTALOBTUNDATION/NEUROLOGICALDEFI
CITS/
SEI
ZURES

.ASK:
i Diabet
es/Tr
auma/Al
cohol
/AnyDr
ugi
ntoxi
cat
ion/

Pr
evi
oushi
stor
yofsei
zur
e/Fev
er/Gast
roUpset/Thy
roi
d/

Li
verdi
sor
der

.CHECK:Bl
i
i oodSugar(
CBG)
/BP/Pul
se/Hear
tsound

i
i
i.SEND:
CBC,
LFT,
Urea,
Creat
ini
ne,
Na,
K,RBS,
Lipi
dPr
ofi
l
e,TSH,

Fev
erscr
een–MPDA,
Widal
,Dengue,
CRP,
Uri
neRE/
ME/
Ket
one

Body

i
v.I
MAGE:CXR,CTBr
ain–NCCT/CECT,
ECG,
USG

.MAI
v NTAI
NABC:I
VFl
uid(
NSi
n

CVA/
Sepsi
s/Dy
sel
ect
rol
ytemi
a,25%Dor10%Dor5%Di
n

hy
pogl
ycaemi
a/al
cohol
int
oxi
cat
ion,
DNSi
nLi
verdi
sor
der
,No

RLi
nLi
verdi
sor
der
,NOI
VFi
nCHF/
CKD)
;Moi
stOxy
genand/
or

Nebul
i
zat
ion;
Ryl
e’
sTubef
eedi
ng;
HighVol
umeNSi
nDKA–1-
2

n1stHour>2Li
Li nnext2Hour>2Li
nnext4-
6Hour
s
v
i.TREATaccor
dingl
y

St
andar
dPr
escr
ipt
ion:

b.CVA:

i
.Ry
le’
stubef
eedi
ng

i
i
.Moi
stO2

i
i
i.I
VFNS500ml
8hour
ly

i
v.I
nj.Manni
tol
20%I
VTDS

v
.Inj
cit
icol
i
ne500mgI
VBD

v
i.I
njPi
racet
am 800mgI
VTDS

v
ii
.Inj
Labet
alol
20mgI
V(i
fpat
ienthy
per
tensi
ve,
andunconsci
ous)

v
ii
i.TabAml
odi
pine5mg(
inconsci
oushy
per
tensi
vepat
ient
)

i
x.I
njPan40I
VOD

x.Tabaspi
ri
n75ODHS(
inI
schemi
cCVA)

xi
.Post
ural
car
e,Pr
oppedupat30degr
ee

c.HYPOGLYCEMI
A:
i
.Sear
chf
orCKD,

i
i
.Gl
ucoset
hroughI
V25%D1-
2ampul
esi
nbol
us,
thenmai
ntai
nIV

gl
ucoseupt
o6-
10hri
fREGULARI
NSULI
Nist
heCause,
24-
36hr

i
nMi
xtar
dINSULI
N,72-
96hri
nOHAbyI
VF5%DorDNS.Check

CBGf
requent
ly.

i
i
i.I
nhy
pogl
ycaemi
ccoma,
wit
hhy
pot
ensi
on-I
VHy
drocor
ti
sone

100mgI
VTDSf
or24-
72hour
s.

d.DKA/
HONK

i
.IVFNS1-
2Li
nFI
RSTHOUR,
anot
her1-
2Li
nnext2hour
s,1-
2L

i
nnext4hour
s,t
henNS4-
6hour
lyt
il
lCBG<250mg

i
i
.Inj
REGULARI
NSULI
NIV0.
1U/
Kguni
tsbol
usandt
hen

0.
1U/
Kg/
Houri
nfusi
ont
il
lCBG250mg.

i
i
i.ChangeI
VFt
o0.
45NSor0.
45%DNSaf
terCBG<250mg,

Mai
ntai
nCBG150-
250mg

i
v.I
VAnt
ibi
oti
cs–PI
P-TAZ/
MEROPENEM,
mai
ntai
nNA/
K

v
.Inj
KCL2ampi
n500ml
NS8hour
lyi
fK<3.
3

e.SEPSI
S:

i
.IVant
ibi
oti
cs–i
njPI
P+TAZ4.
5gm I
VTDS/
QDSorI
nj
MEROPENEM 1gm I
VBD/
TDSandI
njMETROGYLI
VTDSorI
nj

CLI
NDAMYCI
N300I
VTDS.

f
.ALCOHOLI
NTOXI
CATI
ON:

i
.inj
TRI
NEUROSOLH1ml
IM OD,

i
i
.inj
LORAZEPAM 1mg/
DIAZEPAM I
V/I
M BDandSOS

i
i
i.I
VFDNSor5%DI
VTDS

i
v.I
njPPII
VOD

g.SEI
ZURE:

i
.Moi
stO2,

i
i
.IVFDNSorNS6-
8hour
ly

i
i
i.i
njLORAZEPAM 2mg/
DIAZEPAM 5mgI
Vsl
owl
ybol
us,
maybe

r
epeat
edoncemor
e

i
v.i
njPHENYTOI
N100mg8-
10amp=20mg/
kgBW I
Vov
er4-
6

hour
s,t
hen10mg/
KgI
Vov
er4-
6hour
,then100mgI
VTDS,

v
.inj
LEVETI
RACI
TAM 500mgI
VBDi
n100ml
NS,

v
i.I
VPPI

h.BDZpoi
soni
ng:i
njFLUMAZENI
L(ANNEXATE)0.
5mgI
Vst
at

. OPPo
i i
soni
ng:
i
.inj
Atr
opi
ne15-
30ampI
Vst
at,
then5-
15ampI
VTDSi
nIVFt
il
l

f
ull
atr
opi
nisat
ion,

i
i
.inj
PAM I
Vst
atandr
epeatoncewi
thi
n12houri
frequi
red,

i
i
i. Or
orphar
yngeal
suct
ion,

i
v.I
njCef
tri
axone+Met
rogy
l

. SDH–i
j mmedi
ater
efert
oNEUROSURGERY,
IVManni
tol

k.LI
VERf
ail
ure:

i
.inj
Cef
otaxi
me1gm I
VTDS,

i
i
.inj
Decadr
on2ccI
VTDS,

i
i
i.i
njManni
tol
IVTDS,

i
v.I
njLOLAI
VTDS,

v
.inj
Met
rogy
lIVTDS,

v
i.P-
ENEMAandLact
ulose30-
120ml
til
ll
oosemot
ion,

v
ii
.Ry
le’
stube–Ri
faxi
min550BD,
UDI
LIV300BD,
I
NDERAL40-
80

mg/
day
,Di
uret
icsi
frequi
redALDACTONELASI
X

v
ii
i.i
njoct
reot
ide50mi
crogr
am/
hri
nfusi
on

i
x.I
VPPI

x.I
njVi
tKI
VOD
2.PATI
ENTPRESENTEDWI
THRESPI
RATORYDI
STRESS/CHEST

PAI
NORDI
SCOMFORT/CARDI
O_NEUROCOMBI
NEDSYMPTOMS:

a.ASK:Angi
nal
Pai
nonsett
ime/anypr
evi
oussi
mil
arepi
sode/Fev
er/

Tuber
cul
osi
s/Sy
ncopei
nLastoney
ear
/Pr
evi
ousCXRandECG

/
Smoki
ngandAl
cohol
hist
ory/Hemopt
ysi
s

b.CHECK:Pal
l
or,
Cyanosi
s,Cl
ubbi
ng,
Oedema,
JVP,
LungandHear
t

Auscul
tat
ion/Ly
mphnode/BP/Pul
se

c.DOURGENTLY:ECG,CBG,TROP-
T,CXRPA

d.SEND:
Rout
ineBl
oodasment
ionedpr
evi
ousl
y,PLEURALFLUI
D

anal
ysi
s–cel
lcount
,cel
lty
pe,
sugar
,pr
otei
n,LDH,
ADA,
M cel
l

e.I
MAGE:ECHO,CECTTHORAX/
HRCTTHORAX

f
.STANDARDPRESCRI
PTI
ONf
orAMI
:

i
.Moi
stO2

i
i
.IVFNS4-
8hour
lydependi
ngonsi
tuat
ion

i
i
i.Ry
le’
stubeorOr
aldr
ugs–

1.TabAspi
ri
n75mg5t
abst
atandt
hen1t
abOD

2.TabCl
opi
dogr
el75mg4t
abst
atandt
hen1t
abOD

3.TabSobi
tr
ate5mgS/
Lst
atandmayber
epeat
ed5-
10mi
n

i
nter
val
(max3t
ab)
4.TabRami
pri
l1.
25-
10mgperday/Tel
misar
tan20-
80mg

perdayaccor
dingt
oBP

5.TabMet
opr
olol
6.25–50mgperday
/Bi
sopr
olol
1.25-
5

mgperdayaccor
dingt
oBP.DONOTUSEi
nHy
pot
ensi
on,

Hear
tBl
ock,
Brady
car
dia

6.TabAt
orv
ast
ati
n80mgst
att
hen20-
40mgOD/

Rosuv
ast
ati
n40mgst
atand20mgOD

7.Tabcl
onazepam 0.
5ODHS

i
v.I
VPPI

v
.Pl
anf
orThr
ombol
ysi
sinSTEMIof<6-
12Hour
sdur
ati
on,
Check

f
orcont
rai
ndi
cat
ions,
NCCTBr
ain,
theni
njSTREPTOKI
NASE1.
5

mi
l
li
onuni
tIVi
n100ml
NSov
er30-
60mi
ninI
CUwi
thcar
diac

moni
tor
ing,
recheckECG.
..
.ORALTEPLASE15mgI
VBOLUS

ov
er1-
2mi
nut
es,
then50mgi
nfusi
onov
er30mi
n,t
hen35mg

ov
ernextonehour,
ORTENECTAPLASEsi
ngl
eBOLUSdose

ov
er5seconds–30mgi
n<60KG,
35mgi
n60-
70Kg,
40mgi
n

70-
80Kg

v
i.I
fthr
ombol
ysi
snotpossi
bleduet
oLATEARRI
VAL>12hour
,inj

LMWH40-
60mgI
Vst
att
hen40-
60mgS.
CBDf
or5day
s

v
ii
.TabNi
tr
ocont
in2.
6mgBD8AM &3PM orMONOTRATE/
ISMO

30SRODand/
orNI
KORANDI
L5-
10mgOD

v
ii
i.I
nUA/
NSTEMI
,I
njLMWHasdescr
ibedpl
ust
abRANOLAZI
NE
500BDi
ncont
inuouspai
n

i
x.I
ncar
diogeni
cshock,
SBP<90–i
njDOPAMI
NE2ampi
n500ml

NS@ 40mi
crodr
ops/
min,
SBP<70i
njNor
adr
enal
i
ne2ampi
n

500ml
NS@40mi
crodr
ops/
min

x.I
nar
rhy
thmi
ali
keVT,
DCshockori
njAMI
ODARONE300mgI
V

bol
us,
then300mgi
n500ml
NSov
er5-
6hour
,then300mgi
n

500NS8hour
lyi
nnext18hour
.InPSVT,
VERAPAMI
L5-
10mgI
V

ov
er2mi
nut
es,
orDi
l
tiazem 15-
20mgI
Vov
er2mi
n,or

Ami
odar
oneasabov
e

g.CHF:

i
.NOI
VForcont
rol
l
edDNS

i
i
.Moi
stO2

i
i
i.Pr
oppedupposi
ti
on

i
v.I
njLASI
X1-
2ampI
VOD/
BD

v
.TabAl
dact
one25mgOD

v
i.TabAspi
ri
n75OD,
Clopi
dogr
el75OD,
Rami
pri
lorTel
misar
tan

asabov
e,Met
opr
olol
/Bi
sopr
olol
asabov
e,St
ati
nasabov
e

v
ii
.TabLanoxi
n0.
25ODi
nCHFwi
thAF

h.AECOPD/PLEURALEFFUSI
ON/PNEUMOTHORAX:

i
.Moi
stO22-
4L/
min,
but>6Li
npneumot
hor
ax
i
i
.Nebul
i
sat
ionwi
thDuol
i
n6hour
lyandBudecor
t12hour
ly

i
i
i.I
njCoamoxy
clav1.
2gm BD/i
njPI
P+TAZ4.
5gm TDSI
V

i
v.Or
alAzi
thr
omy
cin500mgOD,
DONOTUSEFLUOROQUI
NILONE

v
.Inj
Der
iphy
ll
ineI
VTDS

v
i.I
njHy
drocor
ti
sone100I
VTDSi
nCOPD

v
ii
.ChestMedi
ciner
efer
ral
forPneumot
hor
ax

v
ii
i.I
njLasi
xIVBDi
ncorpul
monal
e

3.PATI
ENTPRESENTEDWI
THFUO/
PUO:

a.ASK,
FEELandCHECK:

Pat
ter
noff
ever–i
nter
mit
tent
/cont
inuous,
OnsetandDur
ati
on,

associ
atedf
eat
ures–chi
l
l/r
igor
,

RASH–l
ocat
ion/dayofappear
ance/t
ypeofr
ash,
Bleedi
ng

mani
fest
ati
ons,

CNS–headache/neckpai
nandst
if
fness/nauseaandv
omi
ti
ng/

di
plopi
a/squi
nt/sei
zur
e/LOC/f
oal
neur
ologi
cal
signs–hemi
par
esi
s,

monopar
esi
s,par
a-orquadr
ipar
esi
s,

RS–cough/hemopt
ysi
s/expect
orat
ion/pai
nchest
/SOB,

CVS–pai
nchest
/dy
spnea/si
gnsofCHF,
GIT–j
aundi
ce/pai
n

abdomen/v
omi
ti
ng/di
arr
hoea/dy
sent
ery
/hemat
ochezi
a/

or
ganomegal
y–l
i
ver
,spl
een,
GENI
TOURI
NARY–l
owerabdomi
nal
pai
n/bur
ningmi
ctur
it
ion/

dy
sur
ia/backpai
n/pusandorbl
oodi
nur
ine/menst
rual
pai
n/whi
te

di
schar
geperv
agi
na/somet
hingcomi
ngoutperv
agi
na,

AUTOI
MMUNE–ar
thr
it
is/
art
hral
gia–numberofswol
l
enandt
ender

j
oint
swi
tht
empor
alpat
ter
nofi
nvol
vement
/phot
osensi
ti
vi
ty/r
ashand

pal
pabl
epur
pur
a/hemat
uri
a/r
aynaud’
sphenomena/ski
nti
ght
eni
ng/

gl
andul
arswel
l
ing/muscl
eweakness/or
alul
cer
s,

I
NFECTI
ON–pasthi
stor
yofTBorcont
actTB,
HIV,
HBV,
HCV,
Blood

t
ransf
usi
onhi
stor
y,occupat
ion,
wor
kingl
onel
ylongdi
stancef
rom

home,
sexual
hist
ory
,tr
avel
toar
easendemi
cforMal
ari
a,kal
a-azar
,

seasonal
disease–dengue,
undert
reat
mentofMDRTy
phoi
d,

BLOOD–st
ernal
tender
ness/l
ymphadenopat
hy/bl
eedi
ng/pur
pur
a,

MALI
GNANCY–Wei
ghtl
oss/speci
fi
csy
stemi
csy
mpt
oms.

b.SEND:

ROUTI
NEBLOOD-CBCwi
thPLATELETSandMPt
hickandt
hinsmear
,

LFT,
RFT-
U/CR,

I
NFECTI
ONSCREEN:Typhi
DOTI
gM,
WIDAL,
MPDA,
DENGUEPROFI
LE,

BLOODCULTURE,
URI
NERE/
ME/
CS,
STOOLRE-
ME/SPUTUM AFB

&CBNAAT

I
MMUNOLOGI
CALSCREEN:ESR,
CRP,
FERRI
TIN,
ANAwi
thENA

PROFI
LE,
RF,
ACPA.

BODYFLUI
DANALYSI
S-CSF/PLEURAL/ASCI
TICFLUI
D–cel
lty
pe,
cel
lcount
,Pr
otei
n,sugarADA,
LDH,
M cel
l
.

SEROLOGY– HI
V,HBV,
HCV

FNACFROM SOLorLN.

c.I
MAGE:CXRPA/USGABDOMEN/CTBRAI
N,THORAX,
ABDOMEN–

NCCTorCECTorHRCT/ECHOCARDI
GRAPHY/ENDOSCOPY–upper

andl
owerGI

d.TREAT:EMPI
RICALasf
oll
ows

i
.Inj
CETRI
AXONE2gm I
VBDorI
njPI
P+TAZ4.
5gm I
VTDSori
nj

MEROPENEM 1gm I
VTDS

i
i
.Inj
VANCOMYCI
N500mgI
VTDS

i
i
i.TabAZI
THROMYCI
N500BD

i
v.I
njMETROGYLI
VTDS

e.MENI
NGOENCEPHALI
TIS:

i
.Inj
DECADRON2ccI
Vst
atandI
VTDS

i
i
.Inj
CETRI
AXONE2gm I
VBDorI
njMEROPENEM 1gm I
VBD

i
i
i.I
njVANCOMYCI
N500mgI
VTDSi
n100ml
NS(
DONOTusei
n

ARF/CKD)

i
v.I
njE-
MAL150mgI
M ODf
or3day
s
v
.Inj
ACYCLOVI
R500mgI
VTDSi
n100ml
NS

v
i.I
njPheny
toi
n100mgI
VTDSorI
njLEVETI
RACETAM 500mgI
V

BDi
n100ml
NS

f
.CEREBRALMALARI
AorCOMPLI
CATEDMALARI
A:

i
.Inj
Decadr
on2ccI
VTDS

i
i
.Inj
ARTESUNATE60mgv
ial
2VI
AL=120mgI
VSTATand

seconddoseaf
ter12hourf
rom 1stdosei
nD1,
then120mgi
.e.

2VI
ALI
VODf
or5day
sfr
om D2–D5. Or
,

I
njQUI
NINE20mg/
kgI
Vfi
rstdoset
hen10mg/
kgI
VTDSi
nIVF

i
i
i.I
VF5%Dor10%Di
ncaseofQui
nine,
andDNSor5%Di
n

Ar
tesunat
eIV6-
8hour
ly

i
v.I
njOndanset
ron4I
VTDS

v
.TabLUMERAX80orLUMETHERFORTE1t
abBDf
or3day
s(I
t

i
sini
ti
alt
reat
mentofuncompl
i
cat
edmal
ari
a)

v
i.SendG6PDandi
nnor
mal
casesgi
veMALI
RIDDS15mgODf
or

14day
s(P.Vi
vax)andMALI
RIDDS15mg3t
aboncei
nP.

f
alci
par
um

g.DENGUEandot
herv
iralf
ever
:

i
.IVFNSorRL(DONOTUSE–DNS/
5%D)I
V4-
6hour
ly
i
i
.ORS2l
i
t/day

i
i
i.TabPARACETAMOL650QDS

i
v.I
VPPI

v
.Inj
ONDEM I
VTDS

v
i.TabAZI
THROMYCI
N500mgBDi
nsel
ect
ivecases

v
ii
.CHECK-PLATELET,
PCV,
SGPT/
SGOTonDAI
LYbasi
s

v
ii
i.Di
schar
geaf
ter36-
72hourofaf
ebr
il
eper
iodandPl
atel
ets

i
ncr
easi
ng>75,
000

i
x.Askt
otakehi
ghpr
otei
nandf
atdi
et

h.MDRTy
phoi
d:

i
.Inj
CEFTRI
AXONE2gm I
VBD

i
i
.TabAZI
THROMYCI
N500mgBD

i
i
i.I
njDECADRON2ccI
VTDSi
nTYPHOI
DSTATEorPsy
chosi
s

i
.GISEPSI
Swi
thDi
arr
hoea(
AGE)

i
.IVFNS6hour
ly

i
i
.Inj
CETRI
AXONE1gm I
VBDorI
njCI
FRANI
VBD

i
i
i.I
njMETROGYLI
VTDS

i
v.CapI
MODI
UM 2mg2capst
atand1capBDt
il
ll
oosemot
ion.

Maxi
mum t
otal
dose16mg.
v
.CapPREBI
OTI
C-PROBI
OTI
CS(
Ent
eroger
mina/Pr
ovi
dac/Bi
fi
lac

HP/Vi
zyl
acRI
CH/VSL#3)
1capBD/
TDS

v
i.I
VPPI

j
.UTI
:

i
.IVFNS6hour
ly

i
i
.Inj
Cet
ri
axone1gm I
VBDorI
njPi
P+Taz4.
5gI
VTDSorI
nj

Mer
openem 1gm I
VTDS

i
i
i.TabNi
tr
ofur
ant
oin100BD/
TDS

i
v.TabURI
SPAS200TDS

v
.Inj
Dicl
ofenacI
M BDi
fpai
nissi
gni
fi
cant

v
i.Sy
rAl
kasol
2tsfTDS

v
ii
.CapTamsul
osi
n0.
4ODHSi
nMal
e

4.PATI
ENTPRESENTEDWI
THACUTEUPPERGIBLEEDI
NG:

a.ASK:Pr
evi
ousUl
cerhi
stor
y/al
cohol
/smoki
ng/NSAI
DS/Fast
ing/

Chr
oni
cLi
verdi
sease/GIcancer
/Bl
ackst
ool
/Bl
eedi
ngsi
mul
taneous

wi
thv
omi
ti
ngorj
ustast
heendoff
orcef
ulv
omi
ti
ng(
esophageal
tear
)/

Aci
dpoi
soni
ng

b.CHECK:Pal
l
or/Cl
ubbi
ng/Vi
rchow’
sandot
herLN/Asci
tesandLi
ver
-
spl
een/aci
dinj
urymar
k/pul
se/
BP

c.SEND:
Rout
ineBl
ood/Gr
oupi
ng–cr
ossmat
chi
ngf
orBl
ood

Tr
ansf
usi
on/ser
ology

d.I
MAGE:UGI
E/xr
ayabdomen

e.TREAT:

i
.IVFNS6hour
ly,
mayneedI
VHemaccel

i
i
.Bl
oodt
ransf
usi
on2uni
ts

i
i
i.I
njPan40mg2VI
ALi
nIVF6-
8hour
lyt
il
lact
ivebl
eedi
ng,
then1

v
ial
IVBD

i
v.I
njTr
anexami
caci
d500I
VTDS

v
.Inj
Lor
azepam 2mg/Di
azepam 5mgI
M BD

v
i.I
njOCTREOTI
DE250mi
crogm I
Vbol
ust
hen50mi
crogr
m/hour

i
nfusi
oni
.e100mg2ampi
neachI
VF

v
ii
.Inj
VitKI
VODf
or3day
s

v
ii
i.i
nACI
DPOI
SONI
NG:
NPM/I
VFDNS/i
njCEFTRI
AXONEand

METROGYL/SUCALFATE/
DIAZEPAM

5.PATI
ENTPRESENTEDWI
THCHRONI
CLI
VERDI
SEASEWI
TH

ASCI
TES:

a.ASK:hi
stor
yofALCOHOL/HBVorHCV/anyDr
ug/Sl
eeppat
ter
n
al
ter
ati
on/Fev
er/upperGIbl
eedi
ng

b.LOOKf
or:
Ast
erexi
s/j
aundi
ce/oedema

c.SEND:
Rout
ineBl
ood/PTI
NR/Ser
ology–HBV,
HCV,
HIV/ASCI
TIC

Fl
uidAnal
ysi
s–cel
lcount
/cel
lty
pe/pr
otei
n/sugar
/LDH/ADA/
M cel
l
/

SAAG

d.I
MAGE:USGabdomen/UGI
E

e.TREAT:

i
.NoI
VForJudi
ciousI
VFDNS12hour
ly.DONOTUSERL

i
i
.Inj
Cef
otaxi
me1gm I
VTDS

i
i
i.I
njLasi
x1ampI
VBD/
TDS

i
v.TabALDACTONE100mgOD/
BD/
TDSdependi
ngonedema

v
.TabI
NDERAL40½t
abBDor1t
abBD

v
i.TabURSODEOXYCHOLI
CACI
D300BD

v
ii
.Sy
rLACTULOSE30-
120ml
perdayi
ndi
vi
deddose

v
ii
i.TabRi
faxi
min550BD

i
x.I
njPPII
VBD

x.I
njVi
tKI
VODf
or3day
s

xi
.Inj
Met
rogy
lIVTDS
xi
i
.Ther
apeut
icaspi
rat
ion1.
5-3L

xi
i
i.I
njHumanAl
bumi
n20%I
Vov
er4-
6hour
sODf
or3day
s,t
hen

t
wiceweekl
y

6.PATI
ENTPRESENTEDWI
THCKD:

a.ASK:Hi
stor
yofHTN/T2DM/AI
CTD/Dr
ug

b.LOOKFOR:oedema/per
icar
it
is/f
eat
uresofCHF/AVf
ist
ula

c.SEND:Rout
ineBl
ood/RENALFUNCTI
ONTEST/SPOTURI
NEACR/

Ser
ology–HBV,
HCV,
HIV/Ca,
PTH,
HCO3

d.I
MAGE:
USGabdomen,
Echocar
diogr
aphy
,ECG,CXRPA

e.TREAT:

i
.NOI
VF

i
i
.Moi
stO2SOS

i
i
i.I
njLASI
X2ampI
VTDS

i
v.TabZy
tani
x2.
5-5mgOD

v
.TabPHOSTATE667BD

v
i.TabNODOSI
S500BD

v
ii
.Inj
DARGEN40SCONCEweekl
yorERYTHROPOI
ETI
N4000SC

t
wiceweekl
y
v
ii
i.TabI
RONOD

i
x.TabCALCI
UM OD

x.ANTI
-HTN:
aml
odi
pin5-
10BD

xi
.IfDi
abet
es:
inj
Regul
ari
nsul
i
n/Li
nagl
i
pti
n

xi
i
.BLOODr
equi
sit
ioni
frequi
red,
NEVERTRANSFUSEBLOODi
n

WARD.Bl
oodTr
ansf
usi
ont
obedonedur
ingHEMODI
ALYSI
S.

xi
i
i.Sendt
hePat
ientt
oHDaf
terpr
epar
ati
oni
fneeded.

7.ATTEMPTEDHANGI
NG:

a.ASK:Ti
me,
Place,
andDur
ati
onofi
nci
dence/Ti
met
akent
ocomet
o

medi
cal
faci
l
ity
/anyot
herassoci
atedpoi
soni
ng

b.LOOK:Li
gat
uremar
ks/Pl
ant
arr
efl
ex/Sei
zur
e/Focal
neur
ologi
cal

si
gns

c.CHECK:
Pul
se/
BP

d.TREAT:

i
.Har
dcer
vical
col
l
ar

i
i
.Moi
stO2

i
i
i.I
VFNS8hour
ly

i
v.I
njMet
hyl
Predni
sol
one30mg/
kg(
1.5–2gm)I
Vov
er30mi
n,

t
hen5.
4mg/
kg/
hri
.e2-
3gm i
neachI
VFbot
tl
eov
er23-
47hr
v
.Inj
PPI

v
i.I
njEPTOI
N100I
Vsos

MANAGEMENTOFSNAKEBI
TE:

 ASK:Ti
meandLocat
ionofBi
te/Hav
eyouseenSNAKE?
/ti
met
o

t
akehospi
tal
faci
l
ity
/anyt
ightbi
ndi
ng/anybl
eedi
ngf
rom

or
if
ices/di
plopi
a/r
espi
rat
orydi
str
essordi
ff
icul
tyi
nbr
eat
hing/

pai
nabdomen

 LOOK:
Local
inj
ury–Bi
temar
ks,
swel
l
ing,
bleedi
ng,
bli
ster
/

Pur
pur
a,ecchy
moses,
bleedi
ngf
rom anysour
ce/Pt
osi
s/Si
gnsof

r
espi
rat
orydi
str
ess/SI
NGLEBREATHCOUNT<28abnor
mal
/

anypr
evi
ousmedi
cat
ion–AVSorphener
gan/chestauscul
tat
ion

–r
honchi
/anyt
ightbi
ndi
ng

 DO:
Opent
ightbi
ndi
ngi
fany
/Immobi
l
izel
i
mbi
nanat
omi
cal

posi
ti
on/mayel
evat
ethel
i
mbathear
tlev
el/Asknott
oWALK/

Resusci
tat
eifr
equi
red

 SEND:
20mi
nut
eWHOLEBLOODCLOTt
est
/Rout
inebl
ood–U,

Cr
/Gr
oupi
ngandCr
ossmat
chi
ng–FFP,
Whol
eBl
ood/CTBr
aini
f

LOCorNeur
ologi
cal
signs/USG–abdi
fpai
nabdomen

 TREAT:
o Moi
stO2SOS

o I
VFNS6-
8hour
ly

o I
njHy
drocor
ti
sone100mgI
VSt
atandsosi
freact
ion

occur
s

o I
njAdr
enal
ine(
1mg/
ml)½ampI
M St
atandSOSi
freact
ion

occur
s

o I
njRant
acI
VSt
atandI
VTDS

o I
njAVS10Vi
ali
n500mlNSov
er60mi
n,St
artsl
owf
or5-

15mi
ntol
ookf
oranyr
eact
ion

o I
njAVS5-
10Vi
ali
n500mlNSov
er30-
60mi
n–MAYBE

REPEATEDi
fsy
mpt
omsper
sist
s–bl
eedi
ng/r
espi
rat
ory

di
str
ess.Tot
al30Vi
alAVScanbei
nfusedi
nav
erage

si
tuat
ion.

o Whol
eBl
oodTr
ansf
usi
onorFFPi
fbl
eedi
ngper
sist
s

o I
njNEOSTI
GMI
NE0.
5mg+I
njATROPI
NE0.
5mgI
VSt
at

andr
epeataf
ter15-
20mi
nint
erv
alI
Mif

Pt
osi
s/Resp.
Dist
ressper
sist
s,oral
ter
nat
ivel
yINJ

NEOSTI
GMI
NE0.
5mg4ampul
esi
n500mlNS,
PLUSi
nj

ATROPI
NE0.
5mgoneampoul
eIVov
er6-
8hour
ly.

o Maybeshi
ft
edt
oICUf
orMechani
cal
Vent
il
ator

o Mayr
equi
reHemodi
aly
sisi
nARF
o I
njPHENERGAN1ampI
M SOSi
nreact
ion.

You might also like